Claybrook Capital’s Boston Scientific BSX Stock Holding History

Claybrook Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-303	Closed	-$11K	–	164
2018 Q4	$11K	Buy	+303	New	+$11K	﹤0.01%	454

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Claybrook Capital's BSX Position: Q1 2019 in Review

Claybrook Capital sold out of Boston Scientific (BSX) in Q1 2019, closing a stake of 303 shares — an estimated $11K sold.

Claybrook Capital first reported a position in BSX in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 788 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

Claybrook Capital reported no remaining Boston Scientific position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 303 Boston Scientific shares in Q1 2019, an estimated $11K.
Claybrook Capital first reported a position in Boston Scientific in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Boston Scientific position peaked at $11K in Q4 2018.
788 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.